Tag: American Academy of Neurology annual meeting
April 25, 2018
Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone
Reata Pharmaceuticals (Nasdaq:RETA) a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that omaveloxolone potently activates the Keap1/Nrf2 pathway,... April 28, 2017